City

Chicago (2)

Zagazig (1)

Condition

Retina Disease (3)

Glaucoma (2)

Normal (2)

Ranibizumab (1)

Retinopathy of Prematurity (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

n/a (2)

phase 3 (1)

Sponsor

Optos, PLC (2)

Zagazig University (1)

Collaborator

Cairo University (1)

Intervention

p200te (2)

predicate (1)

predicate device (1)

ranibizumab (0.25 mg/0.025 ml) (1)

Study Documents

Intervention Type

device (2)

drug (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

retina disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))

Completed

Retina Disease
+2 more

Ranibizumab (0.25 mg/0.025 mL)

Zagazig, Egypt

Zagazig University, Faculty of medicine

Jan 26, 2023

Normal, Retina Disease, Glaucoma Trial in Chicago (P200TE, Predicate)

Recruiting

Normal
+2 more

P200TE
Predicate

Chicago, Illinois

Illinois College of Optometry

Nov 14, 2022

Retina Disease, Glaucoma, Normal Trial in Chicago (P200TE, Predicate Device)

Recruiting

Retina Disease
+2 more

P200TE
Predicate Device

Chicago, Illinois

Illinois College of Optometry

Sep 7, 2022